发布时间：2016-03-07 点击次数：
主 题：Examining Firm Responses to Innovation Policy: An Analysis of Pediatric Exclusivity
主讲人：尹妮娜
摘 要：Our paper examines how firm innovation strategies were affected by the 1997 Pediatric Exclusivity Provision. The innovation policy was adopted to incentivize pediatric studies for medically important drugs, but the policy design may distort firm incentives in ways that could undermine policy goals. We examine the influence of a drug’s medical importance and total sales on FDA’s demand and firms’ supply of pediatric studies. Results provide evidence of policy inefficiency. Firms prioritized pediatric studies for high revenue drugs over drugs that are medically important to children; and pediatric studies for older drugs with less remaining patent life over newer drugs.
关于主讲人：尹妮娜，中央财经大学人力资本与劳动经济研究中心助理教授
时间：2016年3月10日星期四15:40-17:00
地点：学术会堂南楼608室
主办单位：人力资本与劳动经济研究中心
上一条：(2016/3/17)Chunhua Wang:Environmental Regulation, Emissions and Productivity: Evidence from Chinese COD-emitting Manufactures
下一条：中心2016年教师招聘工作正式开始
